ANDA 213456, held by United Res Labs. Colesevelam Hydrochloride.
As of Nov 15, 2026, ANDA 213456 (Colesevelam Hydrochloride), held by United Res Labs, was first approved by FDA on Jan 21, 2022, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 21, 2022 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Colesevelam Hydrochloride625MG ยท tablet;oral | Colesevelam Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters